分享至
16:37 【天宇股份：原料药利伐沙班获得CEP证书】财联社1月27日电，天宇股份公告，公司原料药利伐沙班获得CEP证书。利伐沙班属于抗凝血药物，用于髋关节或膝关节置换手术成年患者。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
